Mon, Jul 28, 2014, 12:13 AM EDT - U.S. Markets open in 9 hrs 17 mins


% | $
Click the to save as a favorite.

Keryx Biopharmaceuticals Inc. Message Board

  • faosto faosto Jun 14, 2013 1:46 PM Flag

    Why does everyone think selling KERX is such a big mystery?

    The CEO said it outright in September of 2011. That was if Persifone was successful, but it failed. Now that Zenerex is successful, there is no reason to think the CEO's position on selling the company has changed. From the Street (Adam Feurstien) in 9/11

    " Keryx Pharmaceuticals (KERX_) will be put up for sale if the company's experimental colon cancer drug succeeds in a late-stage study early next year, the company's CEO said Wednesday.

    "Given the market opportunity in colon cancer, it would be very nice to sell the company," Keryx CEO Ron Bentsur told investors at the Stifel Nicolaus Healthcare Conference.

    Bentsur added that Keryx would consider licensing its colon cancer drug, known as perifosine, or perhaps even sell the drug on its own. Still, his "top priority" would be to find a large pharmaceutical company to acquire the company outright."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Damn did no short seller read this? KERX is for sale, and the drug for sale is worth 1 billion in sales for ESRD, and another 2 billion for CKD. .
      What part of this do you not understand? Where do you think this goes to $4? $3? Tell me! I can't fathom what's going on in your short seller's head here.

15.15+0.29(+1.95%)Jul 25 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.